RIPK1 and amyotrophic lateral sclerosis: The serum RIPK1 levels in B-ALS were higher than in L-ALS and higher circulating RIPK1 levels were found to correlated with the severity of bulbar symptoms, suggesting a preferentially abnormal activation of RIPK1 and necroptosis in ALS with bulbar onset and ALS with more severe bulbar symptoms.